Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
TIGAR deficiency enhances cardiac resilience through epigenetic programming of Parkin expression
Yan Tang, Stanislovas S. Jankauskas, Li Liu, Xujun Wang, Alus M. Xiaoli, Fajun Yang, Gaetano Santulli, Daorong Feng, Jeffrey E. Pessin
Yan Tang, Stanislovas S. Jankauskas, Li Liu, Xujun Wang, Alus M. Xiaoli, Fajun Yang, Gaetano Santulli, Daorong Feng, Jeffrey E. Pessin
View: Text | PDF
Research Article Cardiology Cell biology Metabolism

TIGAR deficiency enhances cardiac resilience through epigenetic programming of Parkin expression

  • Text
  • PDF
Abstract

Mitochondrial dysfunction devastates the heart in major cardiovascular diseases, yet the mechanisms governing mitochondrial quality control remain elusive. We discovered that TIGAR (TP53-induced glycolysis and apoptosis regulator) deficiency established profound cardiac protection through developmental epigenetic programming of Parkin expression. Using mice with whole-body and cardiomyocyte-specific TIGAR knockout, we demonstrated remarkable cardioprotection following myocardial infarction with maintained ejection fraction, and complete resistance to diet-induced cardiac hypertrophy despite comparable weight gain. TIGAR deficiency triggered dramatic increases in Parkin expression across all somatic tissues except testes, where Parkin levels remained extraordinarily high (100-fold greater than cardiac levels) regardless of TIGAR status, revealing tissue-specific regulatory mechanisms. This protection was entirely Parkin dependent, as double-knockout mice lost all cardioprotective benefits. Crucially, adult TIGAR manipulation failed to alter Parkin levels, demonstrating that this pathway operated exclusively during critical developmental windows to program lifelong cardiac resilience. Whole-genome bisulfite sequencing identified reduced DNA methylation in Prkn intron 10 as the key regulatory mechanism, with CRISPR deletion dramatically increasing Parkin expression in multiple cell lines. Our findings reveal how early cardiac metabolism programs lifelong cardiac function through epigenetic mechanisms, and identify developmental metabolic programming as a potential therapeutic target for preventing both ischemic heart disease and metabolic cardiomyopathy.

Authors

Yan Tang, Stanislovas S. Jankauskas, Li Liu, Xujun Wang, Alus M. Xiaoli, Fajun Yang, Gaetano Santulli, Daorong Feng, Jeffrey E. Pessin

×

Figure 1

TIGAR knockout protects against post–myocardial infarction cardiac dysfunction.

Options: View larger image (or click on image) Download as PowerPoint
TIGAR knockout protects against post–myocardial infarction cardiac dysfu...
(A–C) Echocardiograms and quantification of left ventricular ejection fraction (LVEF), mass (LVM), and end-diastolic volume (LVEDV) in 4-month-old male WT (n = 10) and TKO mice (n = 13) 4 weeks after myocardial infarction (MI). MI was induced by left anterior descending (LAD) artery ligation. Sham-operated mice served as controls. (D–F) Echocardiograms and quantification of left ventricular ejection fraction (LVEF), mass (LVM), and end-diastolic volume (LVEDV) in 4-month-old male control Myh6Cre mice (n = 6) and hTKO mice (n = 4) 4 weeks after MI. (G and H) RNA-seq analysis of mitochondrial-encoded genes (G) and nuclear-encoded mitochondrial genes (H) from the infarct zone, expressed as fold changes in TKO versus WT. (I) Immunoblot analysis of TIGAR, troponin I, SERCA2, α-actinin-1, and vinculin in infarcted heart tissue from WT and TKO mice, with normal left ventricular tissue (Control LV) as reference. (J) RNA-seq analysis of cardiac marker genes from the infarct zone, expressed as fold changes in TKO versus WT. For RNA-seq analyses (G, H, and J), RNA from 3 mice per group was pooled for sequencing. Data represent mean ± SD. Statistical significance was determined by 1-way ANOVA. *P < 0.05; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts